Results from 50-Patient Controlled Study Conducted by Bucks County Clinical Research Center Surpass Expectations

SCOTTSDALE, Ariz.–(BUSINESS WIRE)–eFoodSafety.com, Inc. (OTCBB:EFSF), a Company dedicated to improving health conditions around the world through innovative products and technologies, today announced that it has completed a Double Blind Phase I Study on Cinnergenâ„¢, an all natural liquid nutritional supplement designed to regulate blood sugar. The clinical study was conducted by Bucks County Clinical Research Center, which has been doing research for over 20 years for major pharmaceutical companies worldwide. Bucks County Clinical Research Center (www.bccrinc.com) is a fully licensed FDA research center.

The study followed 50 patients with Type I and Type II diabetes over a 90-day period and reported results from a Quality of Life survey completed by each patient. The results from the study showed that 52% of the patients taking 1 ounce of Cinnergenâ„¢ each day exhibited well controlled blood sugars by using Cinnergenâ„¢ alone. The remaining 48% of the patients who used 1 ounce of Cinnergenâ„¢ with their previously prescribed diabetic medications were able to decrease the amount of their medications in order to effectively control their diabetes.

The study also measured the Hemoglobin A1C levels at the beginning and at the conclusion of the study. The diabetic patients on only Cinnergenâ„¢ had an impressive 70% improvement in this important medical monitoring tool which gives an accurate estimate of long-term blood sugar control.

An impressive 75% of study subjects reported positive changes in their Quality of Life, such as convenience of use, pleasant taste, and increase in energy level, as well as improvement in sleep habits, mental alertness, mood, libido, dietary habits, and an overall feeling of well being. They also reported a marked decrease in illness.

The conclusion by Bucks County Clinical Research Center is that all patients, pre-diabetic or diabetic, would benefit from the use of Cinnergenâ„¢ on a daily basis.

Patricia Gruden, President and CEO of eFoodSafety.com, Inc., stated, “With these positive, clinically demonstrated results, which exceeded expectations, we will be able to provide major retailers the opportunity to present Cinnergen™ to their customers with confidence. We expect Cinnergen™ sales to grow significantly as we market our proven claims to our advertisers and retailers, assuring them that they are providing a well studied and quality product that will impact and improve the health and well being of their consumers.”

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company’s Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) – EPA Reg. No. 82723-1 – that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, and Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company’s MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn™-CI/bid Scar Cream, which has been clinically proven to facilitate and improve the appearance, redness, and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn™ line. The company is also owner of Cinnergen™, a clinically studied, non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com). The company has entered into a joint venture agreement with CK41 Direct, Inc. to launch the PurEffect™ anti-acne skin care system.

Please visit the Company’s website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the Company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties and the company’s actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the Company’s products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the Company, and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.

Contacts
Redwood Consultants, LLC
Jens Dalsgaard, 415-884-0348